Literature DB >> 21091779

Exacerbation of Leishmania (Viannia) shawi infection in BALB/c mice after immunization with soluble antigen from amastigote forms.

Luiz Felipe Domingues Passero1, Maria Luiza Antunes Da Costa Bordon, Ana Kely De Carvalho, Luciano Moura Martins, Carlos Eduardo Pereira Corbett, Márcia Dalastra Laurenti.   

Abstract

The present study aimed to evaluate the effects of immunization with soluble amastigote (AmaAg) and promastigote (ProAg) antigens from Leishmania (Viannia) shawi on the course of infection in BALB/c mice. After immunization with AmaAg, the challenged group showed greater lesion size and parasite load in the skin and lymph nodes, associated with diminished interleukin (IL)-2, IL-4, IL-10, interferon (IFN)-γ and nitrate levels in the supernatant of lymph node cell cultures, together with increases in transforming growth factor (TGF)-β concentrations and humoral immune response. In contrast, immunization with ProAg led to smaller lesion size with reduced numbers of viable parasites in the skin. Protection was associated with increases in IL-12, IFN-γ, TGF-β and nitrates and decreases in IL-4 and IL-10 levels. Concerning humoral immune response, a significant reduction in anti-leishmania immunoglobulin G was verified in the ProAg-challenged group. Analysis of these results suggests that AmaAg induced a suppressive cellular immune response in mice, favouring the spread of infection, whereas ProAg induced partial protection associated with increased cellular immune response.
© 2010 The Authors. Journal Compilation © 2010 APMIS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21091779     DOI: 10.1111/j.1600-0463.2010.02679.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  7 in total

1.  Leishmania (Viannia) shawi purified antigens confer protection against murine cutaneous leishmaniasis.

Authors:  Luiz Felipe Domingues Passero; Ana Kely Carvalho; Maria Luiza A C Bordon; Alexis Bonfim-Melo; Marcos Hikari Toyama; Carlos Eduardo Pereira Corbett; Márcia Dalastra Laurenti
Journal:  Inflamm Res       Date:  2011-12-14       Impact factor: 4.575

2.  Treatment with triterpenic fraction purified from Baccharis uncinella leaves inhibits Leishmania (Leishmania) amazonensis spreading and improves Th1 immune response in infected mice.

Authors:  Eduardo Seiji Yamamoto; Bruno Luiz S Campos; Márcia Dalastra Laurenti; João H G Lago; Simone dos Santos Grecco; Carlos E P Corbett; Luiz Felipe D Passero
Journal:  Parasitol Res       Date:  2013-10-31       Impact factor: 2.289

3.  Salivary gland homogenates from wild-caught sand flies Lutzomyia flaviscutellata and Lutzomyia (Psychodopygus) complexus showed inhibitory effects on Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis infection in BALB/c mice.

Authors:  Fernanda C Francesquini; Fernando T Silveira; Luiz Felipe D Passero; Thaise Y Tomokane; Ana Kely Carvalho; Carlos Eduardo P Corbett; Márcia D Laurenti
Journal:  Int J Exp Pathol       Date:  2014-12-05       Impact factor: 1.925

4.  Proteins of Leishmania (Viannia) shawi confer protection associated with Th1 immune response and memory generation.

Authors:  Luiz Felipe D Passero; Ana Kely Carvalho; Maria Lac Bordon; Alexis Bonfim-Melo; Karina Carvalho; Esper G Kallás; Bianca Ba Santos; Marcos H Toyama; Adriana Paes-Leme; Carlos Ep Corbett; Márcia D Laurenti
Journal:  Parasit Vectors       Date:  2012-03-30       Impact factor: 3.876

Review 5.  Antimicrobial activity of oleanolic and ursolic acids: an update.

Authors:  Jéssica A Jesus; João Henrique G Lago; Márcia D Laurenti; Eduardo S Yamamoto; Luiz Felipe D Passero
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-22       Impact factor: 2.629

6.  The Effect of Ursolic Acid on Leishmania (Leishmania) amazonensis Is Related to Programed Cell Death and Presents Therapeutic Potential in Experimental Cutaneous Leishmaniasis.

Authors:  Eduardo S Yamamoto; Bruno L S Campos; Jéssica A Jesus; Márcia D Laurenti; Susan P Ribeiro; Esper G Kallás; Mariana Rafael-Fernandes; Gabriela Santos-Gomes; Marcelo S Silva; Deborah P Sessa; João H G Lago; Débora Levy; Luiz F D Passero
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

7.  Preclinical Assessment of Ursolic Acid Loaded into Nanostructured Lipid Carriers in Experimental Visceral Leishmaniasis.

Authors:  Jéssica Adriana Jesus; Ilza Maria Oliveira Sousa; Thays Nicolli Fragoso da Silva; Aurea Favero Ferreira; Márcia Dalastra Laurenti; Leila Antonangelo; Caroline Silvério Faria; Paulo Cardoso da Costa; Domingos de Carvalho Ferreira; Luiz Felipe Domingues Passero
Journal:  Pharmaceutics       Date:  2021-06-19       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.